日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial

新辅助放化疗联合信迪利单抗治疗中/高免疫评分（SILAR）的错配修复功能正常的局部晚期直肠癌：一项单臂II期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65162-8
Zheng, Xiaobin; Liu, Huashan; Shi, Lishuo; Zeng, Ziwei; Zhang, Xingwei; Luo, Shuangling; Cai, Yonghua; Li, Ze; Liu, Zhanzhen; Hou, Yujie; Yang, Zuli; He, Xiaowen; Ke, Jia; Huang, Liang; Luo, Yanxin; Kang, Liang
肿瘤
肠癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial

经肛门与腹腔镜全直肠系膜切除术治疗直肠癌3年无病生存率比较：TaLaR随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2024.24276
Zeng, Ziwei; Luo, Shuangling; Zhang, Hong; Wu, Miao; Ma, Dan; Wang, Quan; Xie, Ming; Xu, Qing; Ouyang, Jun; Xiao, Yi; Song, Yongchun; Feng, Bo; Xu, Qingwen; Wang, Yanan; Zhang, Yi; Shi, Lishuo; Ling, Li; Zhang, Xingwei; Huang, Liang; Yang, Zuli; Peng, Junsheng; Wu, Xiaojian; Ren, Donglin; Huang, Meijin; Lan, Ping; Wang, Jianping; Tong, Weidong; Ren, Mingyang; Liu, Huashan; Kang, Liang
肠癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phosphorylation of KIAA1429 promotes oxaliplatin resistance through activating the FZD7-Wnt signaling in BRAF(V600E)-mutated colorectal cancer.

KIAA1429 的磷酸化通过激活 BRAF(V600E) 突变结直肠癌中的 FZD7-Wnt 信号通路促进奥沙利铂耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03449-w
Wan Taixuan, He Minyi, Liu Zhanzhen, Zhou Yihang, Zhou Yebohao, Xiao Wei, Xie Hao, Luo Shuangling, Zheng Haoqi, Kang Liang, Shi Yunxing, Huang Liang
信号转导
肠癌
磷酸化
发表日期：2025
文献求助 收藏

Is neoadjuvant chemoradiotherapy necessary for locally advanced rectal cancer above the anterior peritoneal reflection?

对于位于前腹膜反折以上的局部晚期直肠癌，是否需要新辅助放化疗？

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2582211
He, Minyi; Cao, Wuteng; He, Qiulan; Ye, Fujin; Huang, Pinzhu; Wan, Taixuan; Liu, Huashan; Zheng, Xiaobin; Luo, Shuangling; Kang, Liang; Chen, Mian; Huang, Liang
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer

T3N0期直肠癌患者淋巴结阴性与辅助化疗的临床关联

期刊:Gastroenterology Research and Practice
影响因子:1.4
doi:10.1155/grp/3241615
Lei, Dongxu; Liu, Zhanzhen; Kang, Xinyi; Zeng, Ziwei; Xie, Hao; Cai, Tanxing; Ye, Fujin; Xiong, Li; Li, Wenxin; Liang, Zhenxing; Zheng, Xiaobin; Luo, Shuangling; Liu, Huashan
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients

经肛门与腹腔镜全直肠系膜切除术治疗中低位直肠癌的长期肿瘤学疗效：一项纳入2502例患者的回顾性分析

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000992
Li, Ze; Liu, Huashan; Luo, Shuangling; Hou, Yujie; Zhou, Yebohao; Zheng, Xiaobin; Zhang, Xingwei; Huang, Liang; Zeng, Ziwei; Kang, Liang
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Effects of tumour budding on adjuvant chemotherapy in colorectal cancer

肿瘤出芽对结直肠癌辅助化疗的影响

期刊:BJS Open
影响因子:4.5
doi:10.1093/bjsopen/zrad115
Xie, Hao; Zeng, Ziwei; Hou, Yujie; Ye, Fujin; Cai, Tanxing; Cai, Yonghua; Xiong, Li; Li, Wenxin; Liu, Zhanzhen; Liang, Zhenxing; Luo, Shuangling; Zheng, Xiaobin; Huang, Liang; Liu, Huashan; Kang, Liang
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial

经肛门与腹腔镜全直肠系膜切除术治疗直肠癌的短期发病率、死亡率和病理结果：一项多中心随机对照试验的结果

期刊:Annals of Surgery
影响因子:6.4
doi:10.1097/SLA.0000000000005523
Liu, Huashan; Zeng, Ziwei; Zhang, Hong; Wu, Miao; Ma, Dan; Wang, Quan; Xie, Ming; Xu, Qing; Ouyang, Jun; Xiao, Yi; Song, Yongchun; Feng, Bo; Xu, Qingwen; Wang, Yanan; Zhang, Yi; Hao, Yuantao; Luo, Shuangling; Zhang, Xingwei; Yang, Zuli; Peng, Junsheng; Wu, Xiaojian; Ren, Donglin; Huang, Meijin; Lan, Ping; Tong, Weidong; Ren, Mingyang; Wang, Jianping; Kang, Liang
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study

高危病理特征对II期结肠癌患者辅助化疗生存获益的交互作用分析：一项多中心回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11196-4
Li, Kexuan; Zhao, Fuqiang; Guo, Yuchen; Wu, Qingbin; Luo, Shuangling; Zhang, Junling; Li, Heli; Hu, Shidong; Wu, Bin; Lin, Guole; Qiu, Huizhong; Niu, Beizhan; Sun, Xiyu; Xu, Lai; Lu, Junyang; Du, Xiaohui; Wang, Zheng; Wang, Xin; Kang, Liang; Wang, Ziqiang; Wang, Quan; Liu, Qian; Xiao, Yi
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Clinical significance of neoadjuvant chemotherapy for locally advanced colorectal cancer patients with deficient mismatch repair: possibly residual value in the era of immunotherapy

新辅助化疗对错配修复缺陷的局部晚期结直肠癌患者的临床意义：在免疫治疗时代可能仍具有残余价值

期刊:
影响因子:
doi:10.1177/17562848221150306
Chen, Mian; Chen, Junguo; Huang, Jun; Liu, Huashan; Cao, Wuteng; Luo, Shuangling; Liu, Zhanzhen; Hu, Huanxin; Lai, Sicong; Hou, Yujie; Kang, Liang; Huang, Liang
肿瘤
肠癌
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏